MEDXF - Medexus Pharmaceuticals Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript
Medexus Pharmaceuticals, Inc (MEDXF) Q3 2022 Earnings Conference Call February 10, 2022, 08:00 AM ET Company Participants Ken d’Entremont – Chief Executive Officer Marcel Konrad – Chief Financial Officer Victoria Rutherford – Investor Relations Conference Call Participants Andre Uddin – Research Capital Scott Henry – Roth Capital Prasath Pandurangan – Bloom Burton Justin Keywood – Stifel Simon Jarry – Raymond James Allan Ford – Private Investor Presentation Operator Good day, ladies and gentlemen, and welcome to the Medexus Pharmaceuticals Third Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Victoria Rutherford. Ma'am, the floor is yours. Victoria Rutherford Thank you and good morning, everyone. Welcome to the Medexus Pharmaceuticals Third Quarter, Fiscal 2022 Earnings Call. On the
For further details see:
Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript